Risk factors for extrapyramidal reactions from metoclopramide include diabetes mellitus. Unfortunately, this is also a risk factor for developing gastroparesis and metoclopramide is the only FDA ...

2024年1月12日 · The investigational antipsychotic KarXT is effective in reducing positive and negative symptoms of schizophrenia, with a favorable side-effect profile in the pivotal EMERGENT-2 trial.

2024年2月7日 · There was no significant between-group difference in the use of anticholinergic medications to treat extrapyramidal symptoms (22% in the LAI group and 31% in the oral group) despite the LAI group ...

The extrapyramidal symptoms have disappeared. Introduction. The diagnosis of Parkinson's disease (PD) is, most of the times, clinical with sensitivity of 88% and specificity 78%.

2024年4月3日 · The incidence of akathisia and extrapyramidal symptoms was low in the treatment group, and the medication was well tolerated. The most common adverse events were tachycardia, dizziness, dry mouth ...

Hence, there was a clear reduction of the extrapyramidal symptoms. The neuropsychological examination showed an improvement: Trail Making Test, part A: done at 2 minutes and 18 sec, (figure 4 ...

Oct. 2, 2003 — Olanzapine was associated with the fewest patients with extrapyramidal symptoms (EPS) at six months compared with baseline, according to the results of a large prospective trial ...

2020年6月3日 · Ending the common, but unsanctioned, practice of long-term anticholinergic use to head off extrapyramidal symptoms (EPS) associated with antipsychotic medications in patients with serious mental ...

Long-term treatment with FGAs is associated with movement disorders such as tardive dyskinesia and extrapyramidal symptoms (EPS). This is well documented in both adult and pediatric psychiatric ...

2024年9月27日 · Unlike other antipsychotics, xanomeline/trospium did not cause weight gain or extrapyramidal symptoms. "The drug does not have atypical antipsychotic class warnings and precautions and does not ...